4//SEC Filing
Turner Christopher Durant 4
Accession 0001209191-23-052349
CIK 0001861560other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:58 PM ET
Size
18.4 KB
Accession
0001209191-23-052349
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Turner Christopher Durant
Chief Medical Officer
Transactions
- Sale
Class A Common Stock
2023-10-04$57.70/sh−1,465$84,531→ 14,513 total - Exercise/Conversion
Class A Common Stock
2023-10-04$6.89/sh+7,995$55,086→ 22,508 total - Sale
Class A Common Stock
2023-10-04$57.18/sh−500$28,590→ 15,978 total - Sale
Class A Common Stock
2023-10-04$51.32/sh−2,665$136,768→ 19,843 total - Sale
Class A Common Stock
2023-10-04$53.70/sh−2,265$121,631→ 17,578 total - Sale
Class A Common Stock
2023-10-04$54.32/sh−600$32,592→ 16,978 total - Sale
Class A Common Stock
2023-10-04$55.84/sh−500$27,920→ 16,478 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-10-04−7,995→ 303,105 totalExercise: $6.89Exp: 2031-04-29→ Class A Common Stock (7,995 underlying)
Footnotes (8)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 21, 2021.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.15 to $51.49, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.01 to $54.00, inclusive.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.01 to $54.96, inclusive.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.44 to $56.00, inclusive.
- [F6]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.49 to $57.40, inclusive.
- [F7]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.54 to $58.00, inclusive.
- [F8]The shares underlying this option vest as follows: 25% of the shares vested on March 22, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0001862146
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:58 PM ET
- Size
- 18.4 KB